Literature DB >> 27225799

Arsenicosis, possibly from contaminated groundwater, associated with noncirrhotic intrahepatic portal hypertension.

Ashish Goel1, Pamela Christudoss2, Renu George3, Banumathi Ramakrishna4, G Jayakumar Amirtharaj5, Shyamkumar N Keshava6, Anup Ramachandran5, K A Balasubramanian5, Ian Mackie7, Jude J Fleming2, Elwyn Elias1,8, Chundamannil E Eapen9.   

Abstract

BACKGROUND AND AIMS: Idiopathic noncirrhotic intrahepatic portal hypertension (NCIPH), a chronic microangiopathy of the liver caused by arsenicosis from use of contaminated groundwater, was reported from Asia. This study aimed to see, if in the twenty-first century, arsenicosis was present in NCIPH patients at our hospital and, if present, to look for groundwater contamination by arsenic in their residential locality.
METHODS: Twenty-seven liver biopsy proven NCIPH patients, 25 portal hypertensive controls with hepatitis B or C related cirrhosis and 25 healthy controls, matched for residential locality, were studied. Eighty-four percent to 96 % of study subjects belonged to middle or lower socioeconomic category. Arsenicosis was looked for by estimation of arsenic levels in finger/toe nails and by skin examination. Arsenic levels in nails and in ground water (in NCIPH patients with arsenicosis) was estimated by mass spectrometry.
RESULTS: Nail arsenic levels were raised in five (10 %) portal hypertensive study subjects [two NCIPH patients (both had skin arsenicosis) and three portal hypertensive controls]. All of these five patients were residents of West Bengal or Bangladesh. Skin arsenicosis was noted in three NCIPH patients (11 %) compared to none of disease/healthy controls. Ground water from residential locality of one NCIPH patient with arsenicosis (from Bangladesh) showed extremely high level of arsenic (79.5 μg/L).
CONCLUSIONS: Arsenicosis and microangiopathy of liver, possibly caused by environmental contamination continues in parts of Asia. Further studies are needed to understand the mechanisms of such 'poverty-linked thrombophilia'.

Entities:  

Keywords:  Endothelial activation; Liver; Microangiopathy; Noncirrhotic portal fibrosis

Mesh:

Substances:

Year:  2016        PMID: 27225799     DOI: 10.1007/s12664-016-0660-1

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


  39 in total

1.  Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP)

Authors:  H E Gerritsen; P L Turecek; H P Schwarz; B Lämmle; M Furlan
Journal:  Thromb Haemost       Date:  1999-11       Impact factor: 5.249

2.  Kuppuswamy's socioeconomic status scale 2010-the need for periodic revision.

Authors:  Binod Kumar Patro; Kathiresan Jeyashree; Pramod Kumar Gupta
Journal:  Indian J Pediatr       Date:  2011-07-15       Impact factor: 1.967

3.  ADAMTS13 deficiency, despite well-compensated liver functions in patients with noncirrhotic portal hypertension.

Authors:  Ashish Goel; P L Alagammai; Sukesh C Nair; Ian Mackie; Banumathi Ramakrishna; Jayaprakash Muliyil; Shyamkumar N Keshava; C E Eapen; Elwyn Elias
Journal:  Indian J Gastroenterol       Date:  2014-04-24

4.  Arsenic and non-cirrhotic portal hypertension. A report of eight cases.

Authors:  F Nevens; J Fevery; W Van Steenbergen; R Sciot; V Desmet; J De Groote
Journal:  J Hepatol       Date:  1990-07       Impact factor: 25.083

5.  Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment.

Authors:  Shiv Kumar Sarin; Ashish Kumar; Yogesh Kumar Chawla; Sanjay Saran Baijal; Radha Krishna Dhiman; Wasim Jafri; Laurentius A Lesmana; Debendranath Guha Mazumder; Masao Omata; Huma Qureshi; Rizvi Moattar Raza; Peush Sahni; Puja Sakhuja; Mohammad Salih; Amal Santra; Barjesh Chander Sharma; Praveen Sharma; Gamal Shiha; Jose Sollano
Journal:  Hepatol Int       Date:  2007-09-11       Impact factor: 6.047

6.  Chronic arsenic toxicity from drinking tubewell water in rural West Bengal.

Authors:  D N Guha Mazumder; A K Chakraborty; A Ghose; J D Gupta; D P Chakraborty; S B Dey; N Chattopadhyay
Journal:  Bull World Health Organ       Date:  1988       Impact factor: 9.408

Review 7.  Acute and chronic arsenic toxicity.

Authors:  R N Ratnaike
Journal:  Postgrad Med J       Date:  2003-07       Impact factor: 2.401

8.  Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.

Authors:  Pierluigi Toniutto; Carlo Fabris; Davide Bitetto; Edmondo Falleti; Claudio Avellini; Elisabetta Rossi; Carlo Smirne; Rosalba Minisini; Mario Pirisi
Journal:  J Gastroenterol Hepatol       Date:  2007-11       Impact factor: 4.029

9.  Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients.

Authors:  S Hillaire; E Bonte; M-H Denninger; N Casadevall; J-F Cadranel; D Lebrec; D Valla; C Degott
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

10.  Arsenic in ground water in six districts of West bengal, India: the biggest arsenic calamity in the world. Part 2. Arsenic concentration in drinking water, hair, nails, urine, skin-scale and liver tissue (biopsy) of the affected people.

Authors:  D Das; A Chatterjee; B K Mandal; G Samanta; D Chakraborti; B Chanda
Journal:  Analyst       Date:  1995-03       Impact factor: 4.616

View more
  2 in total

1.  ADAMTS13 missense variants associated with defective activity and secretion of ADAMTS13 in a patient with non-cirrhotic portal hypertension.

Authors:  Ashish Goel; V Raghupathy; G J Amirtharaj; Aaron Chapla; Aparna Venkatraman; Banumathi Ramakrishna; Anup Ramachandran; Nihal Thomas; K A Balasubramanian; Ian Mackie; Elwyn Elias; Chundamannil E Eapen
Journal:  Indian J Gastroenterol       Date:  2017-10-05

Review 2.  What makes non-cirrhotic portal hypertension a common disease in India? Analysis for environmental factors.

Authors:  Ashish Goel; Banumathi Ramakrishna; Uday Zachariah; K G Sajith; Deepak K Burad; Thomas A Kodiatte; Shyamkumar N Keshava; K A Balasubramanian; Elwyn Elias; C E Eapen
Journal:  Indian J Med Res       Date:  2019-04       Impact factor: 2.375

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.